BIOTECH Logo

BIOTECH

A biotechnology group offering preclinical services, intein development, and licensing.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera

Description

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-01-18 13:24
Net Asset Value(s)
English 4.0 KB
2024-01-17 11:14
Net Asset Value(s)
English 4.0 KB
2024-01-16 11:42
Net Asset Value(s)
English 4.0 KB
2024-01-15 10:53
Net Asset Value(s)
English 4.1 KB
2024-01-12 12:34
Net Asset Value(s)
English 4.0 KB
2024-01-11 10:16
Net Asset Value(s)
English 4.1 KB
2024-01-10 13:07
Net Asset Value(s)
English 4.1 KB
2024-01-09 11:23
Net Asset Value(s)
English 4.1 KB
2024-01-08 09:19
Net Asset Value(s)
English 4.1 KB
2024-01-05 09:53
Net Asset Value(s)
English 4.0 KB
2024-01-04 09:35
Net Asset Value(s)
English 4.0 KB
2024-01-03 10:56
Net Asset Value(s)
English 4.1 KB
2024-01-02 10:20
Net Asset Value(s)
English 4.1 KB
2023-12-29 08:46
Net Asset Value(s)
English 4.0 KB
2023-12-28 11:53
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IVIM Technology, Inc. Logo
Provides intravital microscopy systems and CRO services for biomedical research.
South Korea
460470
IXICO PLC Logo
Provides AI-driven neuroimaging and data analytics for neuroscience clinical trials.
United Kingdom
IXI
Jade Biosciences, Inc. Logo
A clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.
United States of America
JBIO
Jasper Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies targeting mast and hematopoietic stem cells.
United States of America
JSPR
J. Molner AS Logo
A CDRO developing generic sterile injectable and dermatological dosage forms.
Estonia
JML
Kadimastem Ltd. Logo
Clinical-stage cell therapy company developing treatments for ALS and diabetes.
Israel
KDST
KAINOS MEDICINE, INC. Logo
Develops small molecule therapeutics for neurodegenerative, infectious, and oncological diseases.
South Korea
284620
Kairos Pharma, LTD. Logo
Develops oncology therapies targeting drug resistance and immune suppression.
United States of America
KAPA
Kancera Logo
Pharmaceutical company seeking a reverse takeover to leverage its public listing.
Sweden
KAN
KAZIA THERAPEUTICS LTD Logo
Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.
United States of America
KZIA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.